marketcap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-12-2025
Cue Biopharma ROA Ratio 2011-2025 | CUE
Annual ROA Ratio Cue Biopharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -126.35 | -82.45 | -58.07 | -52.95 | -44.99 | -51.25 | -85.93 | -34.7 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -34.7 | -126.35 | -67.09 |
Quarterly ROA Ratio Cue Biopharma
| 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -83.52 | -59.33 | -75.3 | -74.0 | -50.05 | -64.4 | -62.79 | -60.48 | -45.79 | -62.26 | -48.66 | -60.12 | -42.03 | -52.11 | -45.71 | -45.13 | -33.84 | -43.6 | -43.29 | -45.7 | -38.79 | -66.46 | -84.37 | -87.16 | -60.34 | -67.86 | -47.71 | -38.21 | -19.11 | -19.11 | -11.59 | -5.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -5.0 | -87.16 | -51.37 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Graybug Vision
GRAY
|
-281.96 | $ 0.44 | -11.23 % | $ 9.65 M |  USA |
 |
AgeX Therapeutics
AGE
|
-123.72 | $ 11.3 | -10.17 % | $ 12.2 K | - |
 |
Galera Therapeutics
GRTX
|
-187.67 | $ 0.14 | -32.59 % | $ 7.61 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-251.78 | $ 4.37 | -1.58 % | $ 28.1 M |  China |
 |
Axon Enterprise
AXON
|
8.43 | $ 598.26 | -6.45 % | $ 45.3 B | USA |
 |
Caladrius Biosciences
CLBS
|
-57.1 | $ 0.43 | -16.75 % | $ 25.8 M | USA |
 |
Sorrento Therapeutics
SRNE
|
-61.65 | $ 0.27 | -29.58 % | $ 126 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-10.89 | $ 184.71 | 0.49 % | $ 251 B |  Cayman-islands |
 |
ContraFect Corporation
CFRX
|
-315.07 | $ 1.47 | -5.16 % | $ 5.39 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
-68.82 | $ 4.93 | 1.02 % | $ 90.8 M |  Britain |
 |
Midatech Pharma plc
MTP
|
-42.28 | $ 0.29 | -18.52 % | $ 27.3 M | Britain |
 |
Advaxis
ADXS
|
-289.96 | $ 0.31 | -9.65 % | $ 45.9 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
-20.97 | $ 3.93 | -5.76 % | $ 99.8 M | USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
19.42 | $ 6.2 | - | $ 154 M | USA |
 |
Zymeworks
ZYME
|
-54.44 | $ 6.42 | - | $ 404 M |  Canada |
 |
Aeterna Zentaris
AEZS
|
-10.45 | $ 5.72 | 5.93 % | $ 314 M | Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
-77.89 | $ 10.5 | - | $ 231 M | USA |
 |
Kadmon Holdings, Inc.
KDMN
|
-66.94 | $ 9.5 | - | $ 1.7 B | USA |
 |
BioDelivery Sciences International
BDSI
|
26.14 | $ 2.58 | -4.8 % | $ 255 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
-61.84 | $ 0.56 | 7.23 % | $ 2.72 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-489.29 | $ 0.5 | - | $ 7.46 M |  Israel |
 |
Kiromic BioPharma
KRBP
|
-314.78 | $ 3.15 | 6.61 % | $ 3.08 M | USA |
 |
Acceleron Pharma Inc.
XLRN
|
-13.39 | $ 179.68 | - | $ 10.9 B | USA |
 |
Albireo Pharma
ALBO
|
-11.27 | $ 44.15 | -0.23 % | $ 916 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
-104.58 | $ 0.32 | - | $ 23.9 M | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
-19.73 | $ 18.44 | - | $ 1.94 B | Canada |
 |
Kaleido Biosciences
KLDO
|
-180.08 | $ 0.29 | -3.69 % | $ 12.4 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
-115.2 | $ 2.19 | - | $ 105 M | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | $ 5.25 | -0.38 % | $ 977 M |  Germany |
 |
Humanigen
HGEN
|
-631.8 | $ 0.04 | -81.12 % | $ 4.28 M | USA |
 |
Aptinyx
APTX
|
-97.25 | $ 0.06 | -39.0 % | $ 4.57 M | USA |
 |
Tyme Technologies
TYME
|
-26.28 | $ 0.31 | 8.07 % | $ 54 M | USA |
 |
Evogene Ltd.
EVGN
|
-39.9 | $ 1.16 | -1.69 % | $ 27.9 M | Israel |
 |
Forward Pharma A/S
FWP
|
-2.65 | $ 2.64 | -0.75 % | $ 18.7 M |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | $ 0.39 | - | $ 26.5 M | USA |
 |
Celyad Oncology SA
CYAD
|
-33.16 | $ 0.47 | - | $ 12.5 M |  Belgium |
 |
Brickell Biotech
BBI
|
-49.15 | $ 2.11 | -5.38 % | $ 6.06 M | USA |
 |
Genocea Biosciences
GNCA
|
-59.31 | $ 0.05 | -15.0 % | $ 3.04 M | USA |
 |
Codiak BioSciences
CDAK
|
-21.64 | $ 0.06 | -55.98 % | $ 2.15 M | USA |
 |
FibroGen
FGEN
|
-67.11 | $ 11.04 | 0.33 % | $ 1.07 B | USA |
 |
Concert Pharmaceuticals
CNCE
|
-48.42 | $ 8.37 | - | $ 401 M | USA |
 |
AIkido Pharma
AIKI
|
-31.2 | $ 3.17 | 1.93 % | $ 17.4 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
-31.93 | $ 1.74 | -0.63 % | $ 4.38 M | USA |
 |
Calithera Biosciences
CALA
|
-177.73 | $ 0.37 | -10.95 % | $ 876 K | USA |
 |
Forma Therapeutics Holdings
FMTX
|
-30.83 | $ 20.01 | - | $ 958 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-78.56 | $ 49.55 | -6.81 % | $ 3.04 B | USA |
 |
Sierra Oncology
SRRA
|
-86.55 | $ 54.89 | -0.05 % | $ 1.34 B | Canada |
 |
Regulus Therapeutics
RGLS
|
-97.68 | $ 8.16 | - | $ 155 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
|
Yunhong International
ZGYH
|
-1.14 | $ 10.31 | 0.10 % | $ 92.2 M | China |